{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:30:47Z","timestamp":1790285447842,"version":"4.1.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Key Clinical Specialty Construction Projects"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"DOI":"10.1186\/s12905-026-04285-6","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T18:07:59Z","timestamp":1769105279000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["PAX1\/JAM3 methylation in cervical exfoliated cells: a robust diagnostic biomarker for cervical high-grade lesions associated with vaginal dysbiosis"],"prefix":"10.1186","volume":"26","author":[{"given":"Lianmei","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanruo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youqin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"key":"4285_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"4285_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jncc.2024.01.006","volume":"4","author":"B Han","year":"2024","unstructured":"Han B, Zheng R, Zeng H, Wang S, Sun K, Chen R, et al. Cancer incidence and mortality in China, 2022. J Natl Cancer Cent. 2024;4:47\u201353. https:\/\/doi.org\/10.1016\/j.jncc.2024.01.006.","journal-title":"J Natl Cancer Cent"},{"key":"4285_CR3","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s40477-022-00732-w","volume":"26","author":"PN Nguyen","year":"2023","unstructured":"Nguyen PN, Nguyen VT. Additional value of doppler ultrasound to B-mode ultrasound in assessing for uterine intracavitary pathologies among perimenopausal and postmenopausal bleeding women: A multicentre prospective observational study in Vietnam. J Ultrasound. 2023;26:459\u201369. https:\/\/doi.org\/10.1007\/s40477-022-00732-w.","journal-title":"J Ultrasound"},{"key":"4285_CR4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.4103\/jmh.jmh_81_22","volume":"13","author":"PN Nguyen","year":"2022","unstructured":"Nguyen PN, Nguyen VT. Evaluating clinical features in intracavitary uterine pathologies among Vietnamese women presenting with peri-and postmenopausal bleeding: A bicentric observational descriptive analysis. J Mid-life Health. 2022;13:225\u201332. https:\/\/doi.org\/10.4103\/jmh.jmh_81_22.","journal-title":"J Mid-life Health"},{"key":"4285_CR5","volume-title":"China\u2019s three-level standardized prevention and treatment blue book for cervical cancer","author":"J Lang","year":"2023","unstructured":"Lang J, Cheng F, Wang H, Zhao F. China\u2019s three-level standardized prevention and treatment blue book for cervical cancer. China: People\u2019s Medical Publishing House; 2023."},{"issue":"199909","key":"4285_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(199909):12\u20139. https:\/\/doi.org\/10.1002\/(SICI)1096-9896. )189:1%253C12::AID-PATH431%253E3.0.CO;2-F.","journal-title":"J Pathol"},{"key":"4285_CR7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.bpobgyn.2017.08.015","volume":"47","author":"S de Sanjos\u00e9","year":"2018","unstructured":"de Sanjos\u00e9 S, Brotons M, Pav\u00f3n MA. The natural history of human papillomavirus infection. Best Pract Res Clin Obstet Gynaecol. 2018;47:2\u201313. https:\/\/doi.org\/10.1016\/j.bpobgyn.2017.08.015.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"4285_CR8","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/nrc3728","volume":"14","author":"RD Steenbergen","year":"2014","unstructured":"Steenbergen RD, Snijders PJ, Heideman DA, Meijer CJ. Clinical implications of (epi) genetic changes in HPV-induced cervical precancerous lesions. Nat Rev Cancer. 2014;14:395\u2013405. https:\/\/doi.org\/10.1038\/nrc3728.","journal-title":"Nat Rev Cancer"},{"key":"4285_CR9","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1016\/S0140-6736(21)02178-4","volume":"398","author":"M Falcaro","year":"2021","unstructured":"Falcaro M, Casta\u00f1on A, Ndlela B, Checchi M, Soldan K, Lopez-Bernal J, et al. The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: A register-based observational study. Lancet. 2021;398:2084\u201392. https:\/\/doi.org\/10.1016\/S0140-6736(21)02178-4.","journal-title":"Lancet"},{"key":"4285_CR10","doi-asserted-by":"publisher","first-page":"437","DOI":"10.13390\/j.issn.1672-1861.2023.04.029","volume":"24","author":"M LI","year":"2023","unstructured":"LI M, WEI L, SUI L, Ma D, Kong B, Wu X, et al. Guidelines for cervical cancer screening in China. Chin J Clin Obstet Gynecol. 2023;24:437\u201342. https:\/\/doi.org\/10.13390\/j.issn.1672-1861.2023.04.029.","journal-title":"Chin J Clin Obstet Gynecol"},{"key":"4285_CR11","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/ijc.31261","volume":"143","author":"K Cuschieri","year":"2018","unstructured":"Cuschieri K, Ronco G, Lorincz A, Smith L, Ogilvie G, Mirabello L, et al. Eurogin roadmap 2017: triage strategies for the management of HPV-positive women in cervical screening programs. Int J Cancer. 2018;143:735\u201345. https:\/\/doi.org\/10.1002\/ijc.31261.","journal-title":"Int J Cancer"},{"key":"4285_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-024-01804-w","volume":"16","author":"J Fei","year":"2024","unstructured":"Fei J, Zhai L, Wang J, Zhu X, Liu P, Wang L, et al. Evaluating PAX1\/JAM3 methylation for triage in HPV 16\/18-infected women. Clin Epigenetics. 2024;16:190. https:\/\/doi.org\/10.1186\/s13148-024-01804-w.","journal-title":"Clin Epigenetics"},{"key":"4285_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16071430","volume":"16","author":"M Li","year":"2024","unstructured":"Li M, Zhao C, Zhang X, Li J, Zhao Y, Zhang W, et al. PAX1\/JAM3 methylation and HPV viral load in women with persistent HPV infection. Cancers. 2024;16:1430. https:\/\/doi.org\/10.3390\/cancers16071430.","journal-title":"Cancers"},{"key":"4285_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13027-024-00573-8","volume":"19","author":"J Shen","year":"2024","unstructured":"Shen J, Sun H, Chu J, Gong X, Liu X. Cervicovaginal microbiota: a promising direction for prevention and treatment in cervical cancer. Infect Agents Cancer. 2024;19:13. https:\/\/doi.org\/10.1186\/s13027-024-00573-8.","journal-title":"Infect Agents Cancer"},{"key":"4285_CR15","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1002\/1878-0261.12709","volume":"14","author":"S Yang","year":"2020","unstructured":"Yang S, Wu Y, Wang S, Xu P, Deng Y, Wang M, et al. HPV-related methylation-based reclassification and risk stratification of cervical cancer. Mol Oncol. 2020;14:2124\u201341. https:\/\/doi.org\/10.1002\/1878-0261.12709.","journal-title":"Mol Oncol"},{"key":"4285_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0203403","volume":"13","author":"BA LeConte","year":"2018","unstructured":"LeConte BA, Szaniszlo P, Fennewald SM, Lou DI, Qiu S, Chen N-W, et al. Differences in the viral genome between HPV-positive cervical and oropharyngeal cancer. PLoS One. 2018;13:e0203403. https:\/\/doi.org\/10.1371\/journal.pone.0203403.","journal-title":"PLoS One"},{"key":"4285_CR17","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/s0140-6736(03)12949-2","volume":"361","author":"JS Smith","year":"2003","unstructured":"Smith JS, Green J, Berrington de Gonzalez A, Appleby P, Peto J, Plummer M, et al. Cervical cancer and use of hormonal contraceptives: A systematic review. Lancet (London England). 2003;361:1159\u201367. https:\/\/doi.org\/10.1016\/s0140-6736(03)12949-2.","journal-title":"Lancet (London England)"},{"key":"4285_CR18","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/ng1950","volume":"39","author":"Y Schlesinger","year":"2007","unstructured":"Schlesinger Y, Straussman R, Keshet I, Farkash S, Hecht M, Zimmerman J, et al. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat Genet. 2007;39:232\u20136. https:\/\/doi.org\/10.1038\/ng1950.","journal-title":"Nat Genet"},{"key":"4285_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.bpobgyn.2017.08.001","volume":"47","author":"J Doorbar","year":"2018","unstructured":"Doorbar J. Host control of human papillomavirus infection and disease. Best Pract Res Clin Obstet Gynaecol. 2018;47:27\u201341. https:\/\/doi.org\/10.1016\/j.bpobgyn.2017.08.001.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"4285_CR20","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1128\/CMR.05028-11","volume":"25","author":"MA Stanley","year":"2012","unstructured":"Stanley MA. Epithelial cell responses to infection with human papillomavirus. Clin Microbiol Rev. 2012;25:215\u201322. https:\/\/doi.org\/10.1128\/CMR.05028-11.","journal-title":"Clin Microbiol Rev"},{"key":"4285_CR21","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3969\/j.issn.1674-5671.2024.02.01","volume":"16","author":"Tumor marker committee of Chinese anti-cancer association","year":"2024","unstructured":"Tumor marker committee of Chinese anti-cancer association. Expert consensus on detection and clinical application of tumor DNA methylation markers (Version 2024). Chin J Oncol Prev Treat. 2024;16:129\u201342. https:\/\/doi.org\/10.3969\/j.issn.1674-5671.2024.02.01.","journal-title":"Chin J Oncol Prev Treat"},{"key":"4285_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.13283\/j.cnki.xdfckjz.2025.01.001","volume":"34","author":"M Li","year":"2025","unstructured":"Li M, LI J, Li X, Wang X, Kong L, Cheng F, et al. Guidelines for cervical cancer screening in China \u2161. Chin J Clin Obstet Gynecol. 2025;34:1\u20139. https:\/\/doi.org\/10.13283\/j.cnki.xdfckjz.2025.01.001.","journal-title":"Chin J Clin Obstet Gynecol"},{"key":"4285_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13148-020-00885-7","volume":"12","author":"L Kong","year":"2020","unstructured":"Kong L, Wang L, Wang Z, Xiao X, You Y, Wu H, et al. DNA methylation for cervical cancer screening: a training set in China. Clin Epigenetics. 2020;12:1\u201310. https:\/\/doi.org\/10.1186\/s13148-020-00885-7.","journal-title":"Clin Epigenetics"},{"key":"4285_CR24","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1186\/s12885-024-13299-y","volume":"24","author":"D Sun","year":"2024","unstructured":"Sun D, Shu C, Zeng F, Xu D, Zhao X. The performance of JAM3\/PAX1 methylation in the diagnosis of high-grade squamous intraepithelial lesions for women with high-risk HPV infection. BMC Cancer. 2024;24:1514. https:\/\/doi.org\/10.1186\/s12885-024-13299-y.","journal-title":"BMC Cancer"},{"issue":"1","key":"4285_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-024-01731-w","volume":"16","author":"X Chen","year":"2024","unstructured":"Chen X, Jin X, Kong L, Liou Y, Liu P, Dong Z, et al. Triage performance of PAX1<Superscript>m<\/Superscript>\/JAM3<Superscript>m<\/Superscript> in opportunistic cervical cancer screening of non\u201216\/18 human papillomavirus-positive women: a multicenter prospective study in China. Clin Epigenetics. 2024;16(1):108. https:\/\/doi.org\/10.1186\/s13148-024-01731-w.","journal-title":"Clin Epigenetics"},{"key":"4285_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1481626","volume":"14","author":"H Liang","year":"2024","unstructured":"Liang H, Liu Y, Yin S, Jiang M, Dou Q, Wang H, et al. Assessment of PAX1 and JAM3 methylation triage efficacy across HPV genotypes and age groups in high-risk HPV-positive women in China. Front Oncol. 2024;14:1481626. https:\/\/doi.org\/10.3389\/fonc.2024.1481626.","journal-title":"Front Oncol"},{"key":"4285_CR27","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/s41416-025-03005-5","volume":"132","author":"H Su","year":"2025","unstructured":"Su H, Jin X, Kong L, You Y, Wu H, Liou Y, et al. The triage role of cytological DNA methylation in women with non-16\/18, specifically genotyping high-risk HPV infection. Br J Cancer. 2025;132:1064\u201371. https:\/\/doi.org\/10.1038\/s41416-025-03005-5.","journal-title":"Br J Cancer"},{"issue":"3","key":"4285_CR28","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyae324","volume":"30","author":"L Kong","year":"2024","unstructured":"Kong L, Xiao X, Wu H, You Y, Jin X, Liou Y, et al. Triage performance of DNA methylation for women with high-risk human papillomavirus infection. Oncologist. 2024;oyae324. https:\/\/doi.org\/10.1093\/oncolo\/oyae324.","journal-title":"Oncologist"},{"key":"4285_CR29","doi-asserted-by":"publisher","first-page":"5519","DOI":"10.1002\/jmv.28001","volume":"94","author":"B Dong","year":"2022","unstructured":"Dong B, Huang Y, Cai H, Chen Y, Li Y, Zou H, et al. Prevotella as the hub of the cervicovaginal microbiota affects the occurrence of persistent human papillomavirus infection and cervical lesions in women of childbearing age via host NF-\u03baB\/C-myc. J Med Virol. 2022;94:5519\u201334. https:\/\/doi.org\/10.1002\/jmv.28001.","journal-title":"J Med Virol"},{"key":"4285_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-016-0203-0","volume":"4","author":"A Mitra","year":"2016","unstructured":"Mitra A, MacIntyre DA, Marchesi JR, Lee YS, Bennett PR, Kyrgiou M. The vaginal microbiota, human papillomavirus infection and cervical intraepithelial neoplasia: what do we know and where are we going next? Microbiome. 2016;4:58. https:\/\/doi.org\/10.1186\/s40168-016-0203-0.","journal-title":"Microbiome"},{"key":"4285_CR31","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/j.jiph.2020.05.024","volume":"13","author":"W Cheng","year":"2020","unstructured":"Cheng W, Xu F, Gao L, Liu J. The correlation between the determination of vaginal micro-ecological composition and the outcome of HPV infection by high-throughput metagene sequencing information technology on the illumina platform. J Infect Public Health. 2020;13:1961\u20136. https:\/\/doi.org\/10.1016\/j.jiph.2020.05.024.","journal-title":"J Infect Public Health"},{"key":"4285_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-05324-9","volume":"20","author":"Y Chen","year":"2020","unstructured":"Chen Y, Qiu X, Wang W, Li D, Wu A, Hong Z, et al. Human papillomavirus infection and cervical intraepithelial neoplasia progression are associated with increased vaginal microbiome diversity in a Chinese cohort. BMC Infect Dis. 2020;20:629. https:\/\/doi.org\/10.1186\/s12879-020-05324-9.","journal-title":"BMC Infect Dis"},{"key":"4285_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-12-33","volume":"12","author":"MA Clarke","year":"2012","unstructured":"Clarke MA, Rodriguez AC, Gage JC, Herrero R, Hildesheim A, Wacholder S, et al. A large, population-based study of age-related associations between vaginal pH and human papillomavirus infection. BMC Infect Dis. 2012;12:33. https:\/\/doi.org\/10.1186\/1471-2334-12-33.","journal-title":"BMC Infect Dis"},{"key":"4285_CR34","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1093\/aje\/kwab147","volume":"190","author":"R Turpin","year":"2021","unstructured":"Turpin R, Slopen N, Borgogna J-LC, Yeoman CJ, He X, Miller RS, et al. Perceived stress and molecular bacterial vaginosis in the national institutes of health longitudinal study of vaginal flora. Am J Epidemiol. 2021;190:2374\u201383. https:\/\/doi.org\/10.1093\/aje\/kwab147.","journal-title":"Am J Epidemiol"},{"key":"4285_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28595","volume":"95","author":"Y Liu","year":"2023","unstructured":"Liu Y, Li T, Guo R, Chen T, Wang S, Wu D, et al. The vaginal microbiota among the different status of human papillomavirus infection and bacterial vaginosis. J Med Virol. 2023;95:e28595. https:\/\/doi.org\/10.1002\/jmv.28595.","journal-title":"J Med Virol"},{"key":"4285_CR36","unstructured":"Chinese Society of Clinical Oncology. Guidelines of chinese society of clinical oncology (CSCO). 2023 vision. No. 19, Panjiayuan Nanli, Chaoyang District, Beijing: People\u2018s Medical Publishing House; 2023."},{"key":"4285_CR37","doi-asserted-by":"publisher","first-page":"220","DOI":"10.13390\/j.issn.1672-1861.2022.02.038","volume":"23","author":"C ZHAO","year":"2022","unstructured":"ZHAO C, Bi H, ZHAO Y, Geng L, Liu J, Sheng D, et al. Chinese expert consensus on the management of high-grade squamous intraepithelial lesions of the cervix. Chin J Clin Obstet Gynecol. 2022;23:220. https:\/\/doi.org\/10.13390\/j.issn.1672-1861.2022.02.038.","journal-title":"Chin J Clin Obstet Gynecol"},{"key":"4285_CR38","first-page":"443","volume":"23","author":"H Bi","year":"2022","unstructured":"Bi H, LI M, ZHAO C, Zhao Y, You Z, Gen L, et al. Chinese expert consensus on the management of low-grade squamous intraepithelial lesions of the cervix. Chin J Clin Obstet Gynecol. 2022;23:443\u20135.","journal-title":"Chin J Clin Obstet Gynecol"},{"key":"4285_CR39","doi-asserted-by":"publisher","first-page":"721","DOI":"10.3760\/cma.j.issn.0529-567X.2016.10.001","volume":"51","author":"Cooperative Group of Infectious Disease, Chinese Society of Obstetrics and Gynocology, Chinese Medical Association","year":"2016","unstructured":"Cooperative Group of Infectious Disease, Chinese Society of Obstetrics and Gynocology, Chinese Medical Association. Expert consensus on the clinical application of vaginal microecology test. Chin J Obstet Gynecol. 2016;51:721\u20133. https:\/\/doi.org\/10.3760\/cma.j.issn.0529-567X.2016.10.001.","journal-title":"Chin J Obstet Gynecol"},{"key":"4285_CR40","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3760\/cma.j.cn114452-20241017-00566","volume":"48","author":"Laboratory Medicine Committee of Chinese Association of Integrative Medicine, Chinese Society of Laboratory Medicine, Chinese Laboratory Physician Branch of Chinese Medical Doctor Association, China Maternal and Child Health Association, China International Exchange and Promotive Association for Medical and Health Care","year":"2025","unstructured":"Laboratory Medicine Committee of Chinese Association of Integrative Medicine, Chinese Society of Laboratory Medicine, Chinese Laboratory Physician Branch of Chinese Medical Doctor Association, China Maternal and Child Health Association, China International Exchange and Promotive Association for Medical and Health Care. Expert consensus on the workflow, report, and clinical applications of dual\u2013gene methylation detection of PAX1 and JAM3 for cervical cancer. Chin J Lab Med. 2025;48:192\u2013200. https:\/\/doi.org\/10.3760\/cma.j.cn114452-20241017-00566.","journal-title":"Chin J Lab Med"},{"key":"4285_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-13082-z","volume":"24","author":"X Chen","year":"2024","unstructured":"Chen X, Jiang H, Xu H, Wang L, Liu P, Ma D, et al. Cervical cancer screening: efficacy of PAX1 and JAM3 methylation assay in the triage of atypical squamous cell of undetermined significance (ASC-US). BMC Cancer. 2024;24:1385. https:\/\/doi.org\/10.1186\/s12885-024-13082-z.","journal-title":"BMC Cancer"},{"key":"4285_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.831949","volume":"12","author":"L Zhang","year":"2022","unstructured":"Zhang L, Tan W, Yang H, Zhang S, Dai Y. Detection of host cell gene\/HPV DNA methylation markers: a promising triage approach for cervical cancer. Front Oncol. 2022;12:831949. https:\/\/doi.org\/10.3389\/fonc.2022.831949.","journal-title":"Front Oncol"},{"key":"4285_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/srep16865","volume":"5","author":"A Mitra","year":"2015","unstructured":"Mitra A, MacIntyre DA, Lee YS, Smith A, Marchesi JR, Lehne B, et al. Cervical intraepithelial neoplasia disease progression is associated with increased vaginal microbiome diversity. Sci Rep. 2015;5:16865. https:\/\/doi.org\/10.1038\/srep16865.","journal-title":"Sci Rep"},{"key":"4285_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00181","volume":"5","author":"E Amabebe","year":"2018","unstructured":"Amabebe E, Anumba DOC. The vaginal microenvironment: the physiologic role of lactobacilli. Front Med. 2018;5:181. https:\/\/doi.org\/10.3389\/fmed.2018.00181.","journal-title":"Front Med"},{"key":"4285_CR45","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41585-020-0286-z","volume":"17","author":"P \u0141aniewski","year":"2020","unstructured":"\u0141aniewski P, Ilhan ZE, Herbst-Kralovetz MM. The microbiome and gynaecological cancer development, prevention and therapy. Nat Rev Urol. 2020;17:232\u201350. https:\/\/doi.org\/10.1038\/s41585-020-0286-z.","journal-title":"Nat Rev Urol"},{"key":"4285_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-021-00259-8","volume":"7","author":"P \u0141aniewski","year":"2021","unstructured":"\u0141aniewski P, Herbst-Kralovetz MM. Bacterial vaginosis and health-associated bacteria modulate the immunometabolic landscape in 3D model of human cervix. NPJ Biofilms Microbiomes. 2021;7:88. https:\/\/doi.org\/10.1038\/s41522-021-00259-8.","journal-title":"NPJ Biofilms Microbiomes"},{"issue":"3","key":"4285_CR47","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.semcancer.2022.03.005","volume":"86","author":"M Kyrgiou","year":"2022","unstructured":"Kyrgiou M, Moscicki A-B. Vaginal microbiome and cervical cancer. Semin Cancer Biol. 2022;86(3):189\u201398. https:\/\/doi.org\/10.1016\/j.semcancer.2022.03.005.","journal-title":"Semin Cancer Biol"},{"key":"4285_CR48","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1111\/apm.13356","volume":"132","author":"J Ye","year":"2024","unstructured":"Ye J, Qi X. Vaginal microecology and its role in human papillomavirus infection and human papillomavirus associated cervical lesions. APMIS. 2024;132:928\u201347. https:\/\/doi.org\/10.1111\/apm.13356.","journal-title":"APMIS"},{"key":"4285_CR49","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3620232","volume":"2022","author":"H Zhang","year":"2022","unstructured":"Zhang H, Jin S, Ji A, Zhang C, Shi S. Correlation between vaginal microecological status and prognosis of CIN patients with high-risk HPV infection. Biomed Res Int. 2022;2022:3620232. https:\/\/doi.org\/10.1155\/2022\/3620232.","journal-title":"Biomed Res Int"},{"key":"4285_CR50","doi-asserted-by":"publisher","first-page":"6868","DOI":"10.1002\/jcb.28007","volume":"120","author":"S Ebrahimi","year":"2019","unstructured":"Ebrahimi S, Soltani A, Hashemy SI. Oxidative stress in cervical cancer pathogenesis and resistance to therapy. J Cell Biochem. 2019;120:6868\u201377. https:\/\/doi.org\/10.1002\/jcb.28007.","journal-title":"J Cell Biochem"},{"key":"4285_CR51","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s12602-023-10183-2","volume":"16","author":"S Ashique","year":"2024","unstructured":"Ashique S, Faruk A, Ahmad FJ, Khan T, Mishra N. It is all about probiotics to control cervical cancer. Probiotics Antimicrob Proteins. 2024;16:979\u201392. https:\/\/doi.org\/10.1007\/s12602-023-10183-2.","journal-title":"Probiotics Antimicrob Proteins"},{"key":"4285_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s13027-024-00581-8","volume":"19","author":"A Letafati","year":"2024","unstructured":"Letafati A, Taghiabadi Z, Zafarian N, Tajdini R, Mondeali M, Aboofazeli A, et al. Emerging paradigms: unmasking the role of oxidative stress in HPV-induced carcinogenesis. Infect Agents Cancer. 2024;19:30. https:\/\/doi.org\/10.1186\/s13027-024-00581-8.","journal-title":"Infect Agents Cancer"},{"key":"4285_CR53","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.2147\/IDR.S210615","volume":"13","author":"Y Li","year":"2020","unstructured":"Li Y, Yu T, Yan H, Li D, Yu T, Yuan T, et al. Vaginal microbiota and HPV infection: novel mechanistic insights and therapeutic strategies. Infect Drug Resist. 2020;13:1213\u201320. https:\/\/doi.org\/10.2147\/IDR.S210615.","journal-title":"Infect Drug Resist"},{"key":"4285_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.643422","volume":"12","author":"Y Han","year":"2021","unstructured":"Han Y, Liu Z, Chen T. Role of vaginal microbiota dysbiosis in gynecological diseases and the potential interventions. Front Microbiol. 2021;12:643422. https:\/\/doi.org\/10.3389\/fmicb.2021.643422.","journal-title":"Front Microbiol"},{"key":"4285_CR55","doi-asserted-by":"publisher","first-page":"3423","DOI":"10.1016\/j.vaccine.2018.05.009","volume":"36","author":"A Komatsu","year":"2018","unstructured":"Komatsu A, Igimi S, Kawana K. Optimization of human papillomavirus (HPV) type 16 E7-expressing lactobacillus-based vaccine for induction of mucosal E7-specific IFN\u03b3-producing cells. Vaccine. 2018;36:3423\u20136. https:\/\/doi.org\/10.1016\/j.vaccine.2018.05.009.","journal-title":"Vaccine"},{"key":"4285_CR56","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12879-017-2938-z","volume":"18","author":"E Palma","year":"2018","unstructured":"Palma E, Recine N, Domenici L, Giorgini M, Pierangeli A, Panici PB. Long-term Lactobacillus rhamnosus BMX 54 application to restore a balanced vaginal ecosystem: a promising solution against HPV-infection. BMC Infect Dis. 2018;18:13. https:\/\/doi.org\/10.1186\/s12879-017-2938-z.","journal-title":"BMC Infect Dis"},{"key":"4285_CR57","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.semcancer.2021.06.024","volume":"86","author":"S Haque","year":"2022","unstructured":"Haque S, Raina R, Afroze N, Hussain A, Alsulimani A, Singh V, et al. Microbial dysbiosis and epigenetics modulation in cancer development - a chemopreventive approach. Sem Cancer Biol. 2022;86:666\u201381. https:\/\/doi.org\/10.1016\/j.semcancer.2021.06.024.","journal-title":"Sem Cancer Biol"},{"key":"4285_CR58","first-page":"2723","volume":"31","author":"S Sarkar","year":"2011","unstructured":"Sarkar S, Abujamra AL, Loew JE, Forman LW, Perrine SP, Faller DV. Histone deacetylase inhibitors reverse CpG methylation by regulating DNMT1 through ERK signaling. Anticancer Res. 2011;31:2723\u201332.","journal-title":"Anticancer Res"},{"key":"4285_CR59","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/15592294.2016.1155011","volume":"11","author":"R Cortese","year":"2016","unstructured":"Cortese R, Lu L, Yu Y, Ruden D, Claud EC. Epigenome-microbiome crosstalk: a potential new paradigm influencing neonatal susceptibility to disease. Epigenetics. 2016;11:205\u201315. https:\/\/doi.org\/10.1080\/15592294.2016.1155011.","journal-title":"Epigenetics"},{"key":"4285_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-021-00295-2","volume":"27","author":"A Sipos","year":"2021","unstructured":"Sipos A, Ujlaki G, Mik\u00f3 E, Maka E, Szab\u00f3 J, Uray K, et al. The role of the microbiome in ovarian cancer: mechanistic insights into oncobiosis and to bacterial metabolite signaling. Mol Med. 2021;27:33. https:\/\/doi.org\/10.1186\/s10020-021-00295-2.","journal-title":"Mol Med"},{"key":"4285_CR61","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1158\/0008-5472.CAN-21-0106","volume":"81","author":"L Chen","year":"2021","unstructured":"Chen L, Zhai Y, Wang Y, Fearon ER, N\u00fa\u00f1ez G, Inohara N, et al. Altering the microbiome inhibits tumorigenesis in a mouse model of oviductal high-grade serous carcinoma. Cancer Res. 2021;81:3309\u201318. https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-0106.","journal-title":"Cancer Res"},{"key":"4285_CR62","doi-asserted-by":"publisher","unstructured":"Wahid M, Dar SA, Jawed A, Mandal RK, Akhter N, Khan S et al. Microbes in gynecologic cancers: causes or consequences and therapeutic potential. Seminars Cancer Biology. 2022;86(Pt 2):1179\u201389. https:\/\/doi.org\/10.1016\/j.semcancer.2021.07.013.","DOI":"10.1016\/j.semcancer.2021.07.013"},{"key":"4285_CR63","doi-asserted-by":"publisher","unstructured":"D\u2019Aug\u00e8 TG, Cuccu I, Etrusco A, D\u2019Amato A, Lagan\u00e0 AS, D\u2019Oria O, et al. State of the art on HPV-related cervical lesions. Ital J Gyn\u00e6col Obstet. 2024;36:135\u20137. https:\/\/doi.org\/10.36129\/jog.2024.161.","DOI":"10.36129\/jog.2024.161"},{"key":"4285_CR64","doi-asserted-by":"publisher","DOI":"10.31083\/j.ceog5110235","author":"TG D\u2019Auge","year":"2024","unstructured":"D\u2019Auge TG, Di Donato V, Giannini A. Strategic approaches in management of early-stage cervical cancer: a comprehensive editorial. Clin Exp Obstet Gynecol. 2024. https:\/\/doi.org\/10.31083\/j.ceog5110235.","journal-title":"Clin Exp Obstet Gynecol"},{"key":"4285_CR65","doi-asserted-by":"publisher","unstructured":"Peng H, Li J, Zhou Q, Zhou H, Peng J, Wang J, et al. Enhanced diagnostic accuracy of high-grade cervical intraepithelial neoplasia in postmenopausal women through PAX1\/JAM3 methylation analysis. Int J Cancer. 2025.https:\/\/doi.org\/10.1002\/ijc.70245. IF: 4.7 Q1 B2.","DOI":"10.1002\/ijc.70245"},{"key":"4285_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-45477-5","volume":"9","author":"P-H Su","year":"2019","unstructured":"Su P-H, Lai H-C, Huang R-L, Chen L-Y, Wang Y-C, Wu T-I, et al. Paired box-1 (PAX1) activates multiple phosphatases and inhibits kinase cascades in cervical cancer. Sci Rep. 2019;9:9195. https:\/\/doi.org\/10.1038\/s41598-019-45477-5.","journal-title":"Sci Rep"},{"key":"4285_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-024-03127-7","volume":"24","author":"J Peng","year":"2024","unstructured":"Peng J, Chen Y, Yin A. JAM3 promotes cervical cancer metastasis by activating the HIF-1\u03b1\/VEGFA pathway. BMC Womens Health. 2024;24:293. https:\/\/doi.org\/10.1186\/s12905-024-03127-7.","journal-title":"BMC Womens Health"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-026-04285-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-026-04285-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-026-04285-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T02:03:44Z","timestamp":1771293824000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12905-026-04285-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4285"],"URL":"https:\/\/doi.org\/10.1186\/s12905-026-04285-6","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,22]]},"assertion":[{"value":"5 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of Beijing Anzhen Hospital, Capital Medical University (Approval No. KS2023085). All women enrolled in this study provided written informed consent to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"108"}}